HCP Resource Center

Today, our understanding of the role of genetic factors in heart disease is rapidly increasing and creating an opportunity for more targeted treatments aimed at the underlying cause of a given condition. At Tenaya, we are solely focused on developing new treatments for heart disease by leveraging genetic insights. Partnering with the medical community is key to advancing potentially curative precision medicines for heart disease.

“The future isn’t written in the stars — it’s written in our genome.”
– Jennifer Doudna (Nobel Laureate, co-inventor of CRISPR)

This section of our website is intended to serve as a resource for our medical community (healthcare professionals or “HCPs”) as we collaborate to improve the lives of patients with cardiomyopathies and other heart conditions.